Replimune Group Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-313.94	-247.3	-215.79	-174.28	-118.04
Depreciation & Amortization	6.53	6.61	2.66	2.45	2.15
Stock-Based Compensation	32.27	35.04	34.13	28.13	24.25
Other Adjustments	-1.37	-7.58	-11.94	0.53	2.22
Changes in Accounts Payable	-4.94	9.94	-2.79	1.98	1.12
Changes in Accrued Expenses	2.18	11.74	9.23	11.38	4.73
Changes in Other Operating Activities	-1.09	-0.71	-0.96	1.77	1.39
Operating Cash Flow	-280.34	-192.25	-185.47	-128.05	-82.18
Capital Expenditures	-4.22	-6.69	-5.66	-2.27	-2.34
Purchases of Investments	-77.89	-403.59	-489.52	-583.41	-255.72
Proceeds from Sale of Investments	392.96	386.48	592.38	443.18	256.25
Investing Cash Flow	310.84	-23.8	97.2	-142.5	-1.81
Long-Term Debt Issued	35	-	15	28.15	-
Net Long-Term Debt Issued (Repaid)	35	-	15	28.15	-
Issuance of Common Stock	32.03	253	1.76	283.51	6.86
Net Common Stock Issued (Repurchased)	32.03	253	1.76	283.51	6.86
Other Financing Activities	-0.74	-0.6	-0.48	-0.37	-0.26
Financing Cash Flow	66.29	252.4	16.28	311.3	6.6
Effect of Exchange Rate Changes on Cash and Cash Equivalents	1.11	0.32	-0.09	-0.11	0.82
Net Cash Flow	97.91	36.67	-72.07	40.64	-76.57
Free Cash Flow	-284.57	-198.94	-191.13	-130.32	-84.52
Free Cash Flow Per Share	-3.07	-2.47	-2.87	-2.24	-1.62
Levered Free Cash Flow	-280.47	-226.4	-198.32	-130.83	-110.99
Unlevered Free Cash Flow	-320.89	-241.23	-232.74	-162.07	-111.27

SEC Filings: 10-K · 10-Q